+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2014-05-14Number of Pages: 106

Microfluidic Device System Market - Global Industry Analysis, Trend, Size, Share and Forecast 2016 - 2024

Microfluidics is an evolving scientific field with numerous analytical applications and commercial potential. Globally, the microfluidic device market is witnessing significant growth due to increasing R&D investment in pharmaceuticals, life science and rising point of care testing demand. New trends in healthcare, such as health care at home, supports point of care testing (POCT) as the most efficient and effective delivery of healthcare. Additionally, the microfluidic technique has evolved into a new classification of research areas, targeting integration of laboratory protocols into miniaturized devices called lab on chip. Microfluidic devices offer various advantages for genomics including improved test speed, reduced reagent consumption and efficacy. The global microfluidic device market was valued at USD 1,531.2 million in 2013. It is likely to grow at a CAGR of 22.8% during 2013 to 2019 to reach USD 5,246.4 million in 2019.
 
North America has the largest share in the global microfluidic device market. In-vitro diagnostics is the largest industry, and clinical and veterinary diagnostics is the largest application of microfluidic device market. In terms of growth, Asia is the fastest growing region, medical devices are the fastest growing industry and point of care testing is the fastest growing application of microfluidic devices.
 
The global microfluidic device market was valued at USD 1,531.2 million in 2013 and is expected to reach USD 5,246.4 million in 2019, growing at a CAGR of 22.8% for the period 2013-2019. 
 
North America was valued at USD 644.5 million in 2013 and is expected to reach USD 2,095.5 million in 2019, growing at a CAGR of 21.7% from 2013 to 2019.
 
In-vitro diagnostics microfluidic device market was valued at USD 949.6 million in 2013 and is expected to reach USD 3,317.4 million in 2019, growing at a CAGR of 23.2% from 2013 to 2019.

 
Chapter 1 Preface 11
1.1 Report Description 11
1.2 Research Methodology 12
      1.2.1 Sources 12
              1.2.1.1 Secondary Research 12
              1.2.1.2 Primary Research 12
              1.2.1.3 Assumptions 13
 
Chapter 2 Executive Summary 14
 
Chapter 3 Industry Analysis 16
3.1 Introduction 16
3.2 Market Drivers and Opportunities 18
      3.2.1 Rising demand for point of care testing 18
      3.2.2 Miniaturization of chips, reduces cost of testing 19
      3.2.3 Increasing demand of microfluidic device in genomics and proteomics 19
      3.2.4 Change in material mix provides new opportunities for new players in the market 20
3.3 Restraints and Challenges 20
      3.3.1 Strict regulatory requirements 20
      3.3.2 Geometrical and surface chemistry issues are a challenge for microfluidics 21
 
Chapter 4 Market Trends 23
4.1 Rising number of collaborations and partnerships 23
4.2 Rising number of product innovations 24
 
Chapter 5 Porters Five Force Analysis 25
5.1 Bargaining power of buyers 25
5.2 Bargaining power of suppliers 25
5.3 Threat of new entrants 26
5.4 Threat of substitutes 26
5.5 Degree of competition 26
 
Chapter 6 Global Market Size and Forecast 27
 
Chapter 7 Segment Analysis – by Material 34
7.1 Glass 34
7.2 Polymer 36
7.3 Silicon 38
 
Chapter 8 Segment Analysis – by Industry 41
8.1 In-vitro diagnostics 41
8.2 Pharmaceuticals 43
8.3 Medical Devices 48
 
Chapter 9 Segment Analysis – by Application 52
9.1 Point of care testing 52
9.2 Pharmaceutical and life science research 54
9.3 Drug delivery 57
9.4 Analytical devices 59
9.5 Clinical and veterinary diagnostics 62
9.6 Environment and Industrial 64
 
Chapter 10 Regional Analysis 68
10.1 North America 68
10.2 Europe 70
10.3 Asia 73
10.4 Rest of the World 75
 
Chapter 11 Competitive Landscape 76
 
Chapter 12 Company Profiles 77
12.1 Roche Diagnostics 77
        12.1.1 Overview 77
        12.1.2 Products and segment 77
        12.1.3 Financial Performance 78
        12.1.4 Strategic Development 78
12.2 Abbott Laboratories 80
        12.2.1 Overview 80
        12.2.2 Products and segment 80
        12.2.3 Financial Performance 81
        12.2.4 Strategic Developments 82
12.3 Siemens Healthcare 83
        12.3.1 Overview 83
        12.3.2 Products and segment 83
        12.3.3 Financial Performance 84
        12.3.4 Strategic Development 84
12.4 Agilent Technologies Inc 85
        12.4.1 Overview 85
        12.4.2 Products and segment 85
        12.4.3 Financial Performance 86
12.5 Fluidigm Corporation 87
        12.5.1 Overview 87
        12.5.2 Products and segment 87
        12.5.3 Financial Performance 88
        12.5.4 Strategic Developments 88
12.6 Bio- Rad Laboratories 91
        12.6.1 Overview 91
        12.6.2 Products and segment 91
        12.6.3 Financial Performance 92
        12.6.4 Strategic Developments 92
12.7 Cepheid 94
        12.7.1 Overview 94
        12.7.2 Products and segment 94
        12.7.3 Financial Performance 94
        12.7.4 Strategic Developments 95
12.8 RainDance Technologies 97
        12.8.1 Overview 97
        12.8.2 Products and segment 97
        12.8.3 Financial Performance 97
        12.8.4 Strategic Development 97
12.9 Dolomite Centre 99
        12.9.1 Overview 99
        12.9.2 Products and segment 99
        12.9.3 Financial Performance 99
        12.9.4 Strategic Developments 99
12.10 Micronit Microfluidics 101
        12.10.1 Overview 101
        12.10.2 Products and segment 101
        12.10.3 Financial Performance 101
12.11 Johnson & Johnson 102
        12.11.1 Overview 102
        12.11.2 Product Segment 102
        12.11.3 Financial Performance 103
12.12 Becton, Dickinson and Company 104
        12.12.1 Overview 104
        12.12.2 Products and Segments 104
        12.12.3 Financial performance 105
        12.12.4 Strategic Developments 105

List of Figures 
 
FIG. 1 Applications of Microfluidics 16
FIG. 2 Functions of Microfluidics 17
FIG. 3 Aging population in major regions (% 2000-2050) 18
FIG. 4 Microfluidic Device Market: Porters Five Force Analysis 25
FIG. 5 Global microfluidic device market, by region 2013 (% share) 27
FIG. 6 Global microfluidic device market, by material 2013 (% share) 29
FIG. 7 Global microfluidic device market, by industry 2013 (% share) 30
FIG. 8 Global microfluidic device market, by application 2013 (% share) 32
FIG. 9 Glass microfluidic device market, by region 2013 (% share) 34
FIG. 10 Polymer microfluidic device market, by region 2013 (% share) 36
FIG. 11 Silicon microfluidic device market, by region 2013 (% share) 39
FIG. 12 In-vitro diagnostics industry in microfluidic device market, by region 2013 (% share) 41
FIG. 13 Pharmaceutical industry in microfluidic device market, by region 2013 (% share) 43
FIG. 14 Pharmaceutical industry in microfluidic device market, by product 2013 (% share) 45
FIG. 15 Chips for lab analytics in microfluidic device market, by product 2013 (% share) 47
FIG. 16 Medical device industry in microfluidic device market, by region 2013 (% share) 49
FIG. 17 Medical devices industry in microfluidic device market, by product 2013 (% share) 50
FIG. 18 Microfluidic device material used in point of care testing in 2010 (% share) 52
FIG. 19 Point of care testing in microfluidic device market, by region 2013 (% share) 53
FIG. 20 Microfluidic device material in pharmaceutical and life science research in 2010 (% share) 55
FIG. 21 Pharmaceutical and life science research in microfluidic device market, by region 2013 (% share) 55
FIG. 22 Microfluidic device material in drug delivery in 2010 (% share) 57
FIG. 23 Drug delivery in microfluidic device market, by region 2013 (% share) 58
FIG. 24 Microfluidic device material in analytical devices in 2010 (% share) 60
FIG. 25 Analytical Devices in microfluidic device market, by region 2013 (% share) 60
FIG. 26 Microfluidic device material used in clinical and veterinary diagnosis in 2010 (% share) 62
FIG. 27 Clinical and veterinary diagnosis in microfluidic device market, by region 2013 (% share) 63
FIG. 28 Microfluidic device material in environment and industrial application in 2010 (% share) 65
FIG. 29 Environment and industrial application in microfluidic device market, by region 2013 (% share) 65
FIG. 30 The North American microfluidic device market, by country 2013 (% share) 69
FIG. 31 The European microfluidic device market, by country 2013 (% share) 71
FIG. 32 The Asian microfluidic device market, by country 2013 (% share) 74
FIG. 33 Competitive landscape of global microfluidic device market 76
FIG. 34 Roche sales and net income 2011-2013 (USD Million) 78
FIG. 35 Abbott Laboratories net sales and net earnings 2011-2013 (USD Million) 81
FIG. 36 Siemens revenue and net income 2011-2013 (USD Million) 84
FIG. 37 Agilent Technologies revenue and net income 2011-2013 (USD Million) 86
FIG. 38 Fluidigm Corporation total revenue and net income 2011-2013 (USD Million) 88
FIG. 39 Bio-Rad Laboratories net sales and net income 2010-2012 (USD Million) 92
FIG. 40 Cepheid sales and net income 2011-2013 (USD Million) 95
FIG. 41 Johnson & Johnson sales and net earnings 2011-2013 (USD Million) 103
FIG. 42 Becton, Dickinson and Company revenue and net income 2011-2013 (USD Million) 105

List of Tables
 
TABLE 1 Market Snapshot: microfluidic device market (2013 & 2019) 14
TABLE 2 Drivers for microfluidic devices market: Impact analysis 18
TABLE 3 Restraints for microfluidic devices market: Impact analysis 20
TABLE 4 Major collaborations and partnerships by microfluidic device companies (2011-2013) 23
TABLE 5 Some of the products launched by various companies 24
TABLE 6 Global microfluidic devices market size, by region 2009-2012 (USD million) 28
TABLE 7 Global microfluidic devices market size, by region 2013-2019 (USD million) 28
TABLE 8 Global microfluidic devices market size, by material 2009-2012 (USD million) 29
TABLE 9 Global microfluidic devices market size, by material 2013-2019 (USD million) 30
TABLE 10 Global microfluidic devices market size, by industry 2009-2012 (USD million) 31
TABLE 11 Global microfluidic devices market size, by industry 2013-2019 (USD million) 31
TABLE 12 Global microfluidic devices market size, by application 2009-2012 (USD million) 32
TABLE 13 Global microfluidic devices market size, by application 2013-2019 (USD million) 33
TABLE 14 Glass microfluidic devices market size, by region 2009-2012 (USD million) 35
TABLE 15 Glass microfluidic devices market size, by region 2013-2019 (USD million) 35
TABLE 16 Polymer microfluidic devices market size, by region 2009-2012 (USD million) 37
TABLE 17 Polymer microfluidic devices market size, by region 2013-2019 (USD million) 38
TABLE 18 Silicon microfluidic devices market size, by region 2009-2012 (USD million) 39
TABLE 19 Silicon microfluidic devices market size, by region 2013-2019 (USD million) 40
TABLE 20 In-vitro diagnostic industry in microfluidic devices market size, by region 2009-2012 (USD million) 42
TABLE 21 In-vitro diagnostic industry in microfluidic devices market size, by region 2013-2019 (USD million) 42
TABLE 22 Pharmaceutical industry in microfluidic devices market size, by region 2009-2012 (USD million) 44
TABLE 23 Pharmaceutical industry in microfluidic devices market size, by region 2013-2019 (USD million) 45
TABLE 24 Pharmaceutical industry in microfluidic devices market size, by products 2009-2012 (USD million) 46
TABLE 25 Pharmaceutical industry in microfluidic devices market size, by products 2013-2019 (USD million) 46
TABLE 26 Chips for lab analytics in microfluidic devices market size, by products 2009-2012 (USD million) 47
TABLE 27 Chips for lab analytics in microfluidic devices market size, by products 2013-2019 (USD million) 48
TABLE 28 Medical devices industry in microfluidic devices market size, by region 2009-2012 (USD million) 49
TABLE 29 Medical devices industry in microfluidic devices market size, by region 2013-2019 (USD million) 50
TABLE 30 Medical devices industry in microfluidic devices market size, by products 2009-2012 (USD million) 51
TABLE 31 Medical devices industry in microfluidic devices market size, by products 2013-2019 (USD million) 51
TABLE 32 Point of care testing in microfluidic devices market size, by region 2009-2012 (USD million) 53
TABLE 33 Point of care testing in microfluidic devices market size, by region 2013-2019 (USD million) 54
TABLE 34 Pharmaceutical and life science research in microfluidic devices market size, by region 2009-2012 (USD million) 56
TABLE 35 Pharmaceutical and life science research in microfluidic devices market size, by region 2013-2019 (USD million) 56
TABLE 36 Drug delivery in microfluidic devices market size, by region 2009-2012 (USD million) 58
TABLE 37 Drug delivery in microfluidic devices market size, by region 2013-2019 (USD million) 59
TABLE 38 Analytical devices in microfluidic devices market size, by region 2009-2012 (USD million) 61
TABLE 39 Analytical devices in microfluidic devices market size, by region 2013-2019 (USD million) 61
TABLE 40 Clinical and veterinary diagnostics in microfluidic devices market size, by region 2009-2012 (USD million) 63
TABLE 41 Clinical and veterinary diagnostics in microfluidic devices market size, by region 2013-2019 (USD million) 64
TABLE 42 Environment and industrial application in microfluidic devices market size, by region 2009-2012 (USD million) 66
TABLE 43 Environment and industrial application in microfluidic devices market size, by region 2013-2019 (USD million) 66
TABLE 44 The North American microfluidic devices market size, by country 2009-2012 (USD million) 69
TABLE 45 The North American microfluidic devices market size, by country 2013-2019 (USD million) 70
TABLE 46 The European microfluidic devices market size, by country 2009-2012 (USD million) 71
TABLE 47 The European microfluidic devices market size, by country 2013-2019 (USD million) 72
TABLE 48 The Asian microfluidic devices market size, by country 2009-2012 (USD million) 74
TABLE 49 The Asian microfluidic devices market size, by country 2013-2019 (USD million) 75
TABLE 50 Roche Diagnostics major product categories 77
TABLE 51 Abbott Laboratories major product categories 80
TABLE 52 Siemens Healthcare major product categories 83
TABLE 53 Agilent Technologies major product categories 85
TABLE 54 Major Fluidigm Corporation products and its application 87
TABLE 55 Major Bio-Rad laboratories products and categories 91
TABLE 56 Major Cepheid products and categories 94
TABLE 57 Major RainDance Technologies products and its applications 97
TABLE 58 Major Dolomite Centre products and categories 99
TABLE 59 Major Micronit Microfluidics products and categories 101
TABLE 60 Major Johnson & Johnson segments and products 102
TABLE 61 Major Becton, Dickinson and Company segments and products 104

Global Microfluidic Device System Market: Description

The rising use of microfluidic devices in genomics and proteomics, miniaturization of chips, and point of care testing has been creating lucrative prospects for the global microfluidic device system market. Regionally, the market has been witnessing robust growth in North America. However, in the forthcoming years, the market in Asia Pacific is expected to gain a higher traction. Driven by the strong demand across pharmaceutical and medical devices sector, the future of the global microfluidic device system market seems quite promising. 

The market is poised to witness lucrative opportunities in the forthcoming years. Transparency Market Research’s (TMR) report on the global microfluidic device system market presents in-depth insights into the factors influencing the market’s growth trajectory between 2013 and 2019. For the purpose of the study, the global microfluidic market has been segmented in terms of materials, application, industry, and geography. Based on geography, the market constitutes Asia Pacific, North America, Europe, and Rest of the World.

Besides this, the report examines opportunities for the market in developed and developing markets alike. The impact of the recent regulatory changes in the market’s overall operation is also studied in the report in detail. It also studies the impact of various government regulations on the operations of the market. To study the prevailing competitive landscape, the report also profiles leading companies operating in the market.

Global Microfluidic Device System Market: Overview

As per TMR, the global microfluidic device system market is poised to exhibit a CAGR of 22.8% between 2013 and 2019. The market was valued at US$1.53 bn in 2013 and is expected to reach US$5.24 bn by the end of 2019. The market is significantly gaining from the increasing investment in R&D activities in life science, pharmaceuticals, and point of care testing.

Novel trends in healthcare such as the growing preference for home healthcare are supporting the growth of the point of care testing (POCT) as the most efficient mode of delivery in the healthcare industry. In the last few years, the microfluidic technique has evolved as a new segment of research areas focusing on the integration of laboratory protocols into miniaturized devices. This, combined with various advantages offered such as improved efficacy and test speed and reduced reagent consumption, has been creating lucrative opportunities for the microfluidic device system market.

Conversely, stringent regulations for global affiliations of medical devices are limiting the market’s trajectory to an extent. Besides this, the companies within the market also require to address various geometrical and chemistry related issues to benefit from a sustainable growth.

Regionally, North America emerged as the dominant segment in the global microfluidic device system market in 2013. The region is expected to surge at a CAGR of 21.7% between 2013 and 2019. By industry, the in-vitro diagnostics emerged as the leading segment in 2013. It is expected to report a CAGR of 23.2% during the forecast period.

Companies Mentioned in Report

To study the vendor landscape of the global microfluidic device system market, the report also profiles companies such as Siemens Healthcare, Abbott Laboratories, Agilent Technologies, Fluidigm Corporation, Roche Diagnostics, Johnson & Johnson, Becton Dickinson and Company, and Bio-Rad Laboratories.

Global Microfluidic Device System Market is segmented as:

By Material

  • Glass
  • Polymer
  • Silicon

By Industry

  • In-vitro diagnostics
  • Pharmaceuticals
  • Medical Devices

By Application

  • Point of care testing
  • Pharmaceutical and life science research
  • Drug delivery
  • Analytical devices
  • Clinical and veterinary diagnostics
  • Environment and Industrial

By Region

  • North America
  • Europe
  • Asia
  • Rest of the World

This report gives you access to decisive data such as:

  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for the coming years

Key highlights of this report

  • Overview of key market forces propelling and restraining market growth
  • Up-to-date analyses of market trends and technological improvements
  • Pin-point analyses of market competition dynamics to offer you a competitive edge
  • An analysis of strategies of major competitors
  • An array of graphics and SWOT analysis of major industry segments
  • Detailed analyses of industry trends
  • A well-defined technological growth map with an impact-analysis
  • Offers a clear understanding of the competitive landscape and key product segments


 
 
Back To Top